Cargando…
GABA(B) receptor agonist baclofen promotes central nervous system remyelination
Promoting remyelination is considered as a potential neurorepair strategy to prevent/limit the development of permanent neurological disability in patients with multiple sclerosis (MS). To this end, a number of clinical trials are investigating the potential of existing drugs to enhance oligodendroc...
Autores principales: | Serrano‐Regal, Mari Paz, Bayón‐Cordero, Laura, Chara Ventura, Juan Carlos, Ochoa‐Bueno, Blanca I., Tepavcevic, Vanja, Matute, Carlos, Sánchez‐Gómez, María Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804779/ https://www.ncbi.nlm.nih.gov/pubmed/35980256 http://dx.doi.org/10.1002/glia.24262 |
Ejemplares similares
-
GABA Receptor Agonists Protect From Excitotoxic Damage Induced by AMPA in Oligodendrocytes
por: Bayón-Cordero, Laura, et al.
Publicado: (2022) -
Expression and Function of GABA Receptors in Myelinating Cells
por: Serrano-Regal, Mari Paz, et al.
Publicado: (2020) -
GABA(B)-Agonistic Activity of Certain Baclofen Homologues
por: Attia, Mohamed I., et al.
Publicado: (2013) -
Influence of GABA-B Agonist Baclofen on Capsaicin-Induced Excitation of Secondary Peristalsis in Humans
por: Lei, Wei-Yi, et al.
Publicado: (2017) -
Antitussive effects of the peripherally restricted GABA(B) receptor agonist lesogaberan in guinea pigs: comparison to baclofen and other GABA(B) receptor-selective agonists
por: Canning, Brendan J, et al.
Publicado: (2012)